CSPC Pharmaceutical Group Limited (CSPCY) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CSPC Pharmaceutical Group...

    OTC: CSPCY · Real-Time Price · USD
    4.81
    -0.13 (-2.53%)
    At close: Aug 29, 2025, 3:59 PM
    4.81
    0.00%
    After-hours: Aug 27, 2025, 08:00 PM EDT

    CSPC Pharmaceutical Income Statement

    Financials in CNY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Revenue
    		 16.28B n/a 7.59B 7.78B 8.03B 7.05B 15.1B 16.09B 17B 16.59B
    Cost of Revenue
    		 4.63B n/a 4.33B 2.23B 2.31B 2.22B 4.34B 4.4B 4.16B 3.96B
    Gross Profit
    		 11.65B n/a 10.7B 5.55B 5.72B 4.83B 10.76B 11.68B 12.84B 12.63B
    Operating Income
    		 3.7B n/a 1.79B 1.78B 1.91B 1.53B 3.27B 3.57B 3.79B 3.73B
    Interest Income
    		 n/a n/a n/a n/a 141.15M n/a 141.93M 101.48M 131M 90M
    Pretax Income
    		 3.8B n/a 1.78B 1.93B 1.9B 1.56B 3.82B 3.83B 3.83B 4.39B
    Net Income
    		 3.02B n/a 1.38B 1.53B 1.54B 1.25B 3.08B 3.06B 3.08B 3.67B
    Selling & General & Admin
    		 5.41B n/a 2.79B 2.45B 2.69B 2.41B 5.41B 6.17B 6.85B 6.96B
    Research & Development
    		 2.54B n/a 2.47B 1.37B 1.3B 881.99M 2.07B 1.94B 2.2B 1.94B
    Other Expenses
    		 n/a n/a 2.01B -54.16M n/a 14.57M n/a n/a n/a n/a
    Operating Expenses
    		 7.95B n/a 7.27B 3.77B 4.02B 3.3B 7.48B 8.11B 9.05B 8.9B
    Interest Expense
    		 n/a n/a 9.57M 6.16M 6.29M 3.88M 14.95M 10.02M 3.49M 5.74M
    Selling & Marketing Expenses
    		 4.78B n/a 2.42B 2.13B 2.41B 2.18B 1.95B n/a n/a n/a
    Cost & Expenses
    		 12.58B n/a 5.8B 6B 6.33B 5.52B 11.83B 12.52B 13.21B 12.85B
    Income Tax Expense
    		 749.31M n/a 351.94M 341.23M 311.65M 272.97M 648.16M 713.52M 732.49M 664.48M
    Shares Outstanding (Basic)
    		 2.96B 2.96B 2.96B 2.97B 2.97B 2.98B 2.98B 2.98B 2.99B 2.99B
    Shares Outstanding (Diluted)
    		 2.96B 2.96B 2.96B 2.97B 2.97B 2.98B 2.98B 2.98B 2.99B 2.99B
    EPS (Basic)
    		 1.08 0.56 0.96 0.52 1.12 0.42 1.02 1.02 1.04 1.24
    EPS (Diluted)
    		 1.08 0.56 0.96 0.52 1.12 0.42 1.02 1.02 1.04 1.24
    EBITDA
    		 4.25B n/a 1.79B 1.93B 1.91B 1.56B 3.83B 4.07B 4.32B 4.25B
    EBIT
    		 3.98B n/a 1.79B 1.93B 1.91B 1.53B 2B 1.96B 3.87B 3.72B
    Depreciation & Amortization
    		 549.7M n/a n/a -39.59K 599.69M 35.24M 556.73M 495.45M 525.44M 515.51M

    Add to Watchlist